Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07539987 · ClinicalTrials.gov registry record · NA
Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults
A NA study, sponsored by University of Montana.
- Not yet
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT07539987: Clinical Trial NA study, sponsored by University of Montana.
NCT07539987 is a NA study that has not yet begun recruiting, run by University of Montana. The registered enrollment target is 154 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07539987, a NA study, has not yet begun recruiting, sponsored by University of Montana.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
Particulate matter air pollution is the leading environmental risk factor of cardiovascular disease and is increasing in the Western United States due to more frequent and severe wildfires. Older adults are particularly susceptible to both air pollution exposures and the development of cardiovascular disease, and the older adult population in the United States is rapidly growing. Given the converging threats of worsening air quality and an aging population, this clinical trial will evaluate a novel, multifaceted indoor air quality intervention to improve cardiovascular health outcomes among older adults in the wildfire-impacted state of Montana.
Primary Outcome
Validated cardiovascular disease (CVD) risk score called Predicting Risk of CVD EVENTs (PREVENT). The score is a percentage ranging from 0 to 100 that indicates percentage risk of developing CVD, with higher scores indicating higher risk of developing CVD.
Interventions
- BEHAVIORAL Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE)
- OTHER Portable Air Cleaner (PAC) Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2026-08 |
| Est. Completion | 2030-07 |
| Phase | NA |
What is known before NCT07539987 opens enrollment
NCT07539987 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE) is the first listed.
NCT07539987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07539987 about?
NCT07539987 is a clinical study titled "Evaluation of a Novel Indoor Air Pollution Intervention Among Older Adults". Particulate matter air pollution is the leading environmental risk factor of cardiovascular disease and is increasing in the Western United States due to more frequent and severe wildfires. Older adults are particularly susceptible to both air pollution exposures and the development of cardiovascula...
What is the current status of trial NCT07539987?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 154 participants. The study started on 2026-08. Estimated completion is 2030-07.
What interventions are being tested in trial NCT07539987?
The interventions under investigation include: Air Improvement and Real-time Monitoring for Wellness through Interactive Strategies and Education (AIRWISE) (BEHAVIORAL), Portable Air Cleaner (PAC) Control (OTHER).
Who is sponsoring clinical trial NCT07539987?
This trial is sponsored by University of Montana, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07539987's enrollment target sits among peer trials
154 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia